FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to obstetrics and perinatology, and can be used to predict the risk of developing foetal macrosomia with underlying gestational diabetes mellitus in patients after using assisted reproductive technologies (ART). Up to 22 weeks of pregnancy, the level of aspartate aminotransferase (AST) and high-density lipoprotein (HDL) is determined, PPARG P12A gene polymorphism and duration of post-transfer gestagen support in ART programs with subsequent calculation of prognostic index M. If M > 0, a high risk of developing foetal macrosomia is predicted. If M < 0, no risk of foetal macrosomia is predicted.
EFFECT: method enables predicting the risk of developing foetal macrosomia with underlying gestational diabetes mellitus in the patients after ART by calculating the prognostic index M within 22 weeks of pregnancy.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PREECLAMPSIA WITH UNDERLYING GESTATIONAL DIABETES MELLITUS IN PATIENTS AFTER USING ASSISTED REPRODUCTIVE TECHNOLOGIES | 2023 |
|
RU2821559C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF GESTIONAL DIABETES MELLITUS IN PRIVATE PATIENTS OF LATE REPRODUCTIVE AGE AFTER APPLICATION OF ASSISTANT REPRODUCTIVE TECHNOLOGIES | 2021 |
|
RU2760824C1 |
| METHOD FOR PREDICTION OF RISK OF GESTATIONAL DIABETES MELLITUS IN PREGNANT WOMEN | 2019 |
|
RU2716268C1 |
| METHOD FOR PREDICTION OF GESTATIONAL DIABETES MELLITUS IN WOMEN PLANNING PREGNANCY | 2023 |
|
RU2816803C1 |
| METHOD OF PREVENTING GESTATIONAL DIABETES MELLITUS IN PREGNANT WOMEN DEPENDING ON GENDER OF FETUS | 2022 |
|
RU2810451C1 |
| METHOD FOR PREDICTING FETAL MACROSOMIA IN WOMEN WITH GESTATIONAL DIABETES MELLITUS AND THREAT OF LATE MISCARRIAGE | 2022 |
|
RU2794822C1 |
| METHOD FOR PREDICTING FETAL GROWTH RETARDATION IN WOMEN WITH GESTATIONAL DIABETES MELLITUS AND THREATENED LATE MISCARRIAGE | 2022 |
|
RU2792757C1 |
| METHOD FOR EARLY DIAGNOSIS AND PREDICTION OF DIABETIC FETOPATHY IN GESTATIONAL DIABETES MELLITUS | 2024 |
|
RU2823332C1 |
| METHOD FOR PREDICTION OF HYPERTENSION COMPLICATIONS OF PREGNANCY IN PATIENTS SUFFERING FROM GESTATIONAL DIABETES MELLITUS | 2012 |
|
RU2519083C1 |
| METHOD FOR METABOLIC SYNDROME PREDICTION IN THE II TRIMESTER OF PREGNANCY | 2016 |
|
RU2617182C1 |
